Thomas Marsland

ATLAS: Randomized, Double-Blind, Placebo-Controlled, Phase IIIB Trial Comparing Bevacizumab Therapy With or Without Erlotinib, After Completion of Chemotherapy, With Bevacizumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Bruce E. Johnson, Fairooz F. Kabbinavar, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2013 · 209 citations · Full text

Phase II Study of Trastuzumab plus Gemcitabine in Chemotherapy-Pretreated Patients with Metastatic Breast Cancer

Joyce O’Shaughnessy, S. Vukelja, Thomas Marsland et al. · Clinical Breast Cancer · 2004 · 115 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +7

Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced‐stage nonsmall cell lung cancer

Chandra P. Belani, Marshall T. Schreeder, Ronald G. Steis et al. · Cancer · 2008 · 64 citations · Full text

Phase II Trial of Gemcitabine plus Trastuzumab in Metastatic Breast Cancer Patients Previously Treated with Chemotherapy: Preliminary Results

Joyce O’Shaughnessy, Svetislava J. Vukelja, Thomas Marsland et al. · Clinical Breast Cancer · 2002 · 53 citations

Breast Oncology, Oncology, Phase Ii Trial +6

Pemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer

Joan H. Schiller, Joachim von Pawel, Philipp Schütt et al. · Journal of Thoracic Oncology · 2010 · 51 citations · Full text

Second-line Treatment, Oncology, Pathology +6